NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 49 filers reported holding NEOS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $45,000 | -66.2% | 27,500 | 0.0% | 0.02% | -60.0% |
| Q3 2018 | $133,000 | -22.7% | 27,500 | 0.0% | 0.06% | -32.1% |
| Q2 2018 | $172,000 | -24.6% | 27,500 | 0.0% | 0.08% | -27.0% |
| Q1 2018 | $228,000 | -18.9% | 27,500 | 0.0% | 0.11% | -26.5% |
| Q4 2017 | $281,000 | +11.5% | 27,500 | 0.0% | 0.15% | -3.2% |
| Q3 2017 | $252,000 | -83.6% | 27,500 | -86.9% | 0.16% | -85.7% |
| Q2 2017 | $1,532,000 | +123.3% | 209,873 | +120.3% | 1.09% | +88.4% |
| Q1 2017 | $686,000 | +202.2% | 95,273 | +145.1% | 0.58% | +191.5% |
| Q4 2016 | $227,000 | -11.3% | 38,873 | 0.0% | 0.20% | +11.8% |
| Q3 2016 | $256,000 | -29.1% | 38,873 | 0.0% | 0.18% | -37.8% |
| Q2 2016 | $361,000 | -13.8% | 38,873 | 0.0% | 0.29% | -20.8% |
| Q1 2016 | $419,000 | -53.9% | 38,873 | -38.7% | 0.36% | -55.4% |
| Q4 2015 | $908,000 | -31.8% | 63,400 | 0.0% | 0.81% | -38.8% |
| Q3 2015 | $1,332,000 | – | 63,400 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |